Cited by 136PI3K/AKT/mTOR signaling in cancerBreast Cancer Treatment StudiesHippo pathway signaling and YAP/TAZ

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index; 3 of the 35 sources its claims cite were checked for support.

Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer

Open access

Published version of a preprint

Abstract

Scribble (SCRIB) localizes to cell–cell junctions and regulates establishment of epithelial cell polarity. Loss of expression of SCRIB functions as a tumor suppressor in Drosophila and mammals; conversely, overexpression of SCRIB promotes epithelial differentiation in mammals. Here, we report that SCRIB is frequently amplified, mRNA overexpressed, and protein is mislocalized from cell–cell junctions in human breast cancers. High levels of SCRIB mRNA are associated with poor clinical prognosis, identifying an unexpected role for SCRIB in breast cancer. We find that transgenic mice expressing a SCRIB mutant [Pro 305 to Leu (P305L)] that fails to localize to cell–cell junctions, under the control of the mouse mammary tumor virus long terminal repeat promoter, develop multifocal hyperplasia that progresses to highly pleomorphic and poorly differentiated tumors with basal characteristics. SCRIB interacts with phosphatase and tensin homolog (PTEN) and the expression of P305L, but not wild-type SCRIB, promotes an increase in PTEN levels in the cytosol. Overexpression of P305L, but not wild-type SCRIB, activates the Akt/mTOR/S6K signaling pathway. Human breast tumors overexpressing SCRIB have high levels of S6K but do not harbor mutations in PTEN or PIK3CA, identifying SCRIB amplification as a mechanism of activating PI3K signaling in tumors without mutations in PIK3CA or PTEN. Thus, we demonstrate that high levels of mislocalized SCRIB functions as a neomorph to promote mammary tumorigenesis by affecting subcellular localization of PTEN and activating an Akt/mTOR/S6kinase signaling pathway. Cancer Res; 74(11); 3180–94. ©2014 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-13-3415

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

73 Own result · 38 Own interpretation · 27 Not checked yet · 1 Supported · 1 Partly supported · accuracy not yet measured

Verify all 32 references — free account
  • It may state two separate claims as one. 43
  • Probably not a substantial claim. 12
  • The quote only partly states this claim. 1
51 of 51
  • The paper relies on this without support.

    The tumorigenic effect in hSCRIBP305L mice is attributable to SCRIB mislocalization rather than to SCRIB overexpression alone.

    “To investigate the effect of expressing Scribble that does not localize to cell-cell junctions, we generated a transgenic mouse expressing hSCRIBP305L”
  • The paper relies on this without support.

    The hSCRIBP305L transgene is the cause of the mammary tumors, not spontaneous or insertional mutagenesis.

    “Virgin hSCRIBP305L mice, but not FVB control mice, developed regions of hyperplastic growth”
  • The paper relies on this without support.

    Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.

    “Phosphorylation of Akt at 308 and 473 is associated with an increase in its kinase activity.”
  • The paper relies on this without support.

    SCRIB mislocalization is highly prevalent in human tumors.

    “Therefore, multiple distinct mechanisms may account for the high prevalence of SCRIB mislocalization observed human tumors.”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

Sorted by citations

See all 136

Metadata

Authors
Feigin, M. E., Akshinthala, S. D., Araki, K., Rosenberg, A. Z., Muthuswamy, L. B., Martin, B., Lehmann, B. D., Berman, H. K., Pietenpol, J. A., Cardiff, R. D., & Muthuswamy, S. K.
Affiliations
Ontario Institute for Cancer Research (CA)
Corresponding author
Muthuswamy, Senthil K.
Venue
Cancer Research
Published
2014-05-29
Volume
74
Issue
11
Pages
3180-3194
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2107089643
Cited by
135
References
49
Citations by year
2026: 8 · 2025: 8 · 2024: 5 · 2023: 11 · 2022: 15 · 2021: 6 · 2020: 9 · 2019: 14 · 2018: 11 · 2017: 16 · 2016: 16 · 2015: 11 · 2014: 4
FWCI
6.43
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Cancer Institute (CA105388, U01CA105388, CA098830, R56CA098830, P30CA093373, R01CA098830)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
Keywords
Scribble, SCRIB, breast cancer, basal-like breast cancer, cell polarity, cell-cell contact, protein mislocalization, PTEN, PI3K signaling, mammary carcinogenesis, tumor suppressor, epithelial differentiation, transgenic mice
MeSH terms
Animals, Breast Neoplasms, Cell Line, Female, Humans, Membrane Proteins, Mice, Transgenic, Signal Transduction, Gene Expression, Cell Polarity, Phosphatidylinositol 3-Kinases, Tumor Suppressor Proteins, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice, HEK293 Cells, Class I Phosphatidylinositol 3-Kinases, TOR Serine-Threonine Kinases, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review